Woodline Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,967
Closed -$5.3M 983
2024
Q4
$5.3M Buy
+15,967
New +$5.42M 0.04% 475
2022
Q2
Sell
-28,370
Closed -$4.64M 850
2022
Q1
$4.64M Buy
+28,370
New +$4.68M 0.08% 253

Other funds holding MEDP

Woodline Partners's MEDP Position: Q1 2025 in Review

Woodline Partners sold out of Medpace (MEDP) in Q1 2025, closing a stake of 15,967 shares — an estimated $5.3M sold.

Woodline Partners first reported a position in MEDP in Q1 2022 and held it in 2 quarters. The position peaked at $5.3M in Q4 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Woodline Partners reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Woodline Partners sold 15,967 Medpace shares in Q1 2025, an estimated $5.3M.
  • Woodline Partners first reported a position in Medpace in Q1 2022 and held it in 2 quarters.
  • Woodline Partners's Medpace position peaked at $5.3M in Q4 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Woodline Partners's 13F filing for Q1 2025, filed 15 May 2025.